THE COLOPHON
About Glow Compound: a reading-room on the GLOW peptide literature.
An independent editorial project that sets the published research down as study plates — not a clinic, not a pharmacy, not a vendor.
What this project is
Glow Compound is an independent editorial project that publishes summaries of the peer-reviewed research literature on GLOW peptide — the GHK-Cu + BPC-157 + TB-500 research blend — and on each of its three constituents. We read the published record and set it down plainly: what the studies measured, at what dose, in which species, and with every quantitative claim cited.
We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science, organized so a reader can see exactly where a claim comes from and how far it actually reaches.
Why "Compound" is editorial, not a counter
The word "compound" in our name is read in its apothecary and formulary sense — a compounded preparation, an entry in the materia-medica record — not a pharmacy checkout. It is editorial framing: the position a publisher occupies relative to the literature, cataloguing and annotating it, not a claim that this site dispenses, prescribes, or supplies anything. Nothing here is for sale.
That distinction is load-bearing for GLOW specifically, because the blend is not a single approved drug and its regulatory story is mixed. We keep the GLOW legal status and 503A compounding access record in the margin precisely so the science and the regulatory facts stay separate and clearly sourced.
How we handle the evidence
Two rules govern every page. First, we never blur the constituent and the blend: where a finding is a GHK-Cu, BPC-157 or TB-500 result, we say so, and we do not let it stand in for a blend that has never been tested as a unit [10]. Second, every quantitative claim — every dose, percentage, half-life and effect size — maps to a numbered source in the full reference list. Where the human evidence is thin, we say that plainly; recent reviews treat these compounds as investigational, and so do we [11].
The lithograph framing of this site is deliberate. A turn-of-the-century materia-medica printed a substance, its character, and the caveats attached to it as a single annotated plate — figure in the foreground, status noted in the margin. That is the register we keep: the constituents drawn as study plates, the established findings marked plainly, and the regulatory record set in the margin rather than buried. The ornament is structure, not decoration; it exists to make the hierarchy of what is known and what is merely claimed legible at a glance.